TrialInvestigational new drugs2012

Combined treatment with bevacizumab and standard chemotherapy restores abnormal immune parameters in advanced colorectal cancer patients.

Nikolaos Tsavaris et al.PubMed ↗Publisher ↗

No numbers read from the abstract.